bioRxiv ScienceSearch

bioRxiv · 10.1101/503565

A novel structure-based control method for analyzing nonlinear dynamics in biological networks

Abstract

Exploring complex biological systems requires adequate knowledge of the systems underlying wiring diagram but not its specific functional forms. Thus, exploration actually requires the concepts and approaches delivered by structure-based network control, which investigates the controllability of complex networks through a minimum set of input nodes. Traditional structure-based control methods focus on the structure of complex systems with linear dynamics and may not match the meaning of control well in some biological systems. Here we took into consideration the nonlinear dynamics of some biological networks and formalized the nonlinear control problem of undirected dynamical networks (NCU). Then, we designed and implemented a novel and general graphic-theoretic algorithm (NCUA) from the perspective of the feedback vertex set to discover the possible minimum sets of the input nodes in controlling the network state. We applied our NCUA to both synthetic networks and real-world networks to investigate how the network parameters, such as the scaling exponent and the degree heterogeneity, affect the control characteristics of networks with nonlinear dynamics. The NCUA was applied to analyze the patient-specific molecular networks corresponding to patients across multiple datasets from The Cancer Genome Atlas (TCGA), which demonstrates the advantages of the nonlinear control method to characterize and quantify the patient-state change over the other state-of-the-art linear control methods. Thus, our model opens a new way to control the undesired transition of cancer states and provides a powerful tool for theoretical research on network control, especially in biological fields.\n\nAuthor summaryComplex biological systems usually have nonlinear dynamics, such as the biological gene (protein) interaction network and gene co-expression networks. However, most of the structure-based network control methods focus on the structure of complex systems with linear dynamics. Thus, the ultimate purpose to control biological networks is still too complicated to be directly solved by such network control methods. We currently lack a framework to control the biological networks with nonlinear and undirected dynamics theoretically and computationally. Here, we discuss the concept of the nonlinear control problem of undirected dynamical networks (NCU) and present the novel graphic-theoretic algorithm from the perspective of a feedback vertex set for identifying the possible sets with minimum input nodes in controlling the networks. The NCUA searches the minimum set of input nodes to drive the network from the undesired attractor to the desired attractor, which is different from conventional linear network control, such as that found in the Maximum Matching Sets (MMS) and Minimum Dominating Sets (MDS) algorithms. In this work, we evaluated the NCUA on multiple synthetic scale-free networks and real complex networks with nonlinear dynamics and found the novel control characteristics of the undirected scale-free networks. We used the NCUA to thoroughly investigate the sample-specific networks and their nonlinear controllability corresponding to cancer samples from TCGA which are enriched with known driver genes and known drug target as controls of pathologic phenotype transitions. We found that our NCUA control method has a better predicted performance for indicating and quantifying the patient biological system changes than that of the state-of-the-art linear control methods. Our approach provides a powerful tool for theoretical research on network control, especially in a range of biological fields.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Guo, W.-F., Zhang, S.-W., Zeng, T., Li, Y., Gao, J., Chen, L.. 2018-12-21. A novel structure-based control method for analyzing nonlinear dynamics in biological networks. https://doi.org/10.1101/503565

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

INFORME: coupling information-theoretic experimental design with nonlinear mixed-effects modeling for efficient observation scheduling

Mathematical models of treatment response can inform individualized therapy, but their calibration often requires longitudinal measurements that are costly, burdensome, and collected on fixed schedules. Such schedules may be inefficient, over-sampling patients whose response is already well characterized while delaying informative measurements for those whose model parameters remain uncertain. We present INFORME (INFORmation-theoretic design with Mixed Effects), a framework that combines Bayesian information-theoretic experimental design with nonlinear mixed-effects modeling to adaptively select each patients next measurement time. Population and response-subgroup parameter distributions learned from an existing cohort provide informative priors, allowing candidate measurement times to be ranked by their expected reduction in patient-specific parameter uncertainty. As observations accumulate, priors can be updated to reflect the response subgroup most consistent with the patients data. We evaluate INFORME in two radiotherapy datasets: 150 synthetic tumor volume trajectories from a hybrid cellular automaton model of prostate cancer spheroids (HD1) and longitudinal tumor volumes from 39 patients with head-and-neck cancer (HD2). In HD1, population priors allowed omission of both pretreatment scans, while adaptive scheduling reduced the protocol from nine scans to three or four, with the response group identified from a single post-treatment scan on day 27. In HD2, the adaptive schedule used three scans instead of six and improved prediction by delaying the first on-treatment scan from week 1 to week 2, avoiding transient dynamics that produced false-positive and false-negative response projections. Across both datasets, the adaptive schedules used a mean of 2.7 scans in stead of seven and advanced completion of the patient-specific prediction by a mean of 15.5 days (95% CI, 6.7-24.3) relative to the equidistant protocol, while treatment duration remained unchanged. INFORME therefore reduces measurement burden and accelerates patient-specific prediction by concentrating observations at times that are most informative for model calibration.

systems biology

Sobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. Our group previously identified the antifibrotic potential of thyroid hormone, triiodothyronine (T3); however, clinical translation of thyroid hormone therapy is limited by its systemic adverse effects. In this study, we investigate whether sobetirome, a selective and well tolerated thyroid hormone receptor beta (THRB) agonist, offers antifibrotic benefits of thyroid hormone while minimizing systemic toxicity. Our study reveals that sobetirome, administered via intraperitoneal or inhalational routes, effectively mitigates bleomycin-induced pulmonary fibrosis in mice, with no evidence of toxicity. We identified that sobetirome restores mitochondrial homeostasis via activating the THRB-PPARGC1a axis. This protects alveolar type II epithelial cells from injury-induced apoptosis while selectively inducing apoptosis and metabolic reprogramming in apoptosis resistant IPF fibroblasts. Cell-specific deletion of Ppargc1a in either alveolar epithelial cells or fibroblasts abolishes sobetirome-mediated protection, establishing PPARGC1a as an essential mediator of therapeutic response. Importantly, sobetirome reverses fibrosis-associated transcriptional programs in human IPF lung tissue, reducing expression of key fibrosis-associated genes, including collagen I alpha 1 (COL1A1), collagen III alpha 1 (COL3A1), periostin (POSTN), cathepsin K (CTSK), and Chitinase 3 Like 1 (CHI3L1), while promoting extracellular matrix remodeling, epithelial restoration, and tissue homeostasis. Collectively, our findings identify THRB activation as a novel metabolic strategy for reversing pulmonary fibrosis. Across complementary in vitro, in vivo, and human ex vivo models, sobetirome restores mitochondrial function, modulates apoptotic pathways in pathogenic cells, and promotes fibrosis resolution, highlighting its potential as a lung-targeted therapeutic approach for IPF and other fibrotic lung diseases.

systems biology

Mechanistic modeling of bacterial translation initiation across growth conditions

Translation frequency in bacteria depends on how ribosomes, mRNAs, and initiation factors are allocated across growth conditions. Here, we developed a mechanistic ODE-based model of Escherichia coli translation that represents initiation, elongation, termination, and coupled auxiliary processes. Growth-dependent abundances were derived from physiological relationships and reprocessed omics data, and simulated outputs were compared with translation-frequency and active-ribosome references. The model predicts a continuous shift from complex-formation-limited toward ribosome-limited behavior as growth increases. This shift is characterized by a decline in free-ribosome abundance, whereas initiation-factor pools remain largely unbound and do not become depleted in parallel. Together with the implemented IF-dependent kinetic term, this preserved availability provides a model-internal route through which productive initiation can be maintained despite increasing ribosome utilization. Consistently, transcript-wide ribosome loading remains below its theoretical maximum, while COG-level simulations reveal distinct sector-specific translation-frequency trajectories. The study therefore provides a resource-allocation framework for interpreting how mRNA--ribosome interactions shape bacterial translation across growth conditions.

systems biology